
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-6.76%
-4.90%
+1.58%
+1.95%
+0.87%
14 Jun 2026$IOT Samsara is among the companies Goldman Sachs believes can continue leading the market despite geopolitical uncertainty, inflation concerns, and questions surrounding economic growth. The investment bank is focusing on businesses that combine operational stability with durable growth drivers, favoring companies across software, healthcare, consumer products, and artificial intelligence where demand tends to remain resilient during economic slowdowns. This positioning reflects a broader search for earnings momentum and sustainable business models capable of performing through volatile market conditions.
Samsara develops connected systems for managing vehicle fleets, industrial equipment, and enterprise operations through internet connected sensors and cloud based platforms. Goldman describes the company as one of the most resilient growth stories in software, supported by organizations consolidating operational tools onto a smaller number of platforms. Analysts expect profitability to improve in the coming years as the company expands its customer base and increases market penetration. The stock has advanced roughly 18% over the past month, reinforcing expectations for continued earnings momentum.
$BTSG BrightSpring Health Services is one of Goldmans preferred ideas. The company benefits from long term demographic trends tied to an aging population and the continued shift of medical treatments from hospitals and clinics into patients homes. Analysts believe its presence in specialty pharmacy, home infusion therapy, and community healthcare services creates a competitive advantage within the US healthcare market. Shares have gained approximately 67% since the start of the year, supported by favorable industry trends and growing institutional flows toward healthcare services providers.
$ULTA Ulta Beauty was highlighted despite the stock weakness earlier this year. The bank believes the company continues to strengthen its competitive position in the US beauty market and gain share from rivals. Concerns raised by some investors following recent earnings results were viewed as excessive relative to actual performance, as the company maintained its revenue outlook and raised guidance for both operating profit and earnings per share. Investments in marketing, workforce development, and customer services are viewed as supporting future growth and potential multiple expansion.
$NVDA Nvidia remains a favored technology name. Despite substantial gains over recent years, analysts believe the company maintains a significant competitive advantage in artificial intelligence semiconductors. The firms capital allocation strategy and continued investment across its ecosystem are viewed as reinforcing investor confidence. Goldman expects growth to remain strong as demand for AI computing infrastructure continues to expand.
$JNJ Johnson & Johnson is viewed as a more defensive investment opportunity. The company benefits from a broad pharmaceutical portfolio and a strong balance sheet that provides flexibility for investment, acquisitions, and business expansion. Analysts believe the market is not fully recognizing the growth potential of its innovative medicines division. Strong financial resources also position the company to pursue strategic transactions while maintaining operational stability.
The list assembled by Goldman Sachs reflects a growing preference for companies that combine growth potential with business resilience. Rather than concentrating solely on higher risk technology stocks, the bank is emphasizing businesses operating in markets with durable demand and the ability to continue expanding through more challenging economic environments.
Curated for you
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Curated for you
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.